The TNBS-induced colitis animal model: An overview

Annals of Medicine and Surgery

Volumn 11, Issue , 2016, Pages 9-15

  Antoniou, Efstathios ^a   Margonis, Georgios Antonios ^a   Angelou, Anastasios ^a   Pikouli, Anastasia ^a   Argiri, Paraskevi ^b   Karavokyros, Ioannis ^a   Papalois, Apostolos ^c   Pikoulis, Emmanouil ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b GENERAL HOSPITAL OF LARISSA   (Greece)

^c ELPEN   (Greece)

Author keywords

Animal model; Colitis; Crohn's disease; TNBS

Indexed keywords

CALGRANULIN; CISAPRIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRINITROBENZENESULFONIC ACID; VANILLOID RECEPTOR 1;

ANIMAL MODEL; APOPTOSIS; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CROHN DISEASE; DISEASE SEVERITY; ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SCORING SYSTEM; TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS; ULCERATIVE COLITIS;

EID: 84984829207     PISSN: 20490801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amsu.2016.07.019     Document Type: Review

References (42)

1. [1] Baumgart, D.C., Sandborn, W.J., Crohn's disease. Lancet 380:9853 (2012), 1590–1605, 10.1016/S0140-6736(12)60026-9 [PMID: 22914295].
2. [2] Fuss, I.J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R.S., Mannon, P., Strober, W., Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Investig. 113:10 (2004), 1490–1497, 10.1172/JCI19836 [PMID: 15146247 PMCID: 406524].
3. [3] Moncada, D.M., Kammanadiminti, S.J., Chadee, K., Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol. 19:7 (2003), 305–311 [PMID: 12855381].
4. [4] Zhang, H.Q., Ding, T.T., Zhao, J.S., Yang, X., Zhang, H.X., Zhang, J.J., Cui, Y.L., Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World J. Gastroenterol. WJG 15:15 (2009), 1821–1828 [PMID: 19370778 PMCID: 2670408].
5. [5] Iseri, S.O., Ersoy, Y., Ercan, F., Yuksel, M., Atukeren, P., Gumustas, K., Alican, I., The effect of sildenafil, a phosphodiesterase-5 inhibitor, on acetic acid-induced colonic inflammation in the rat. J. Gastroenterol. Hepatol. 24:6 (2009), 1142–1148, 10.1111/j.1440-1746.2009.05797.x [PMID: 19638092].
6. [6] Watanabe, T., Asano, N., Murray, P.J., Ozato, K., Tailor, P., Fuss, I.J., Kitani, A., Strober, W., Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Investig. 118:2 (2008), 545–559, 10.1172/JCI33145 [PMID: 18188453 PMCID: 2176188].
7. [7] Yang, Z., Fuss, I.J., Watanabe, T., Asano, N., Davey, M.P., Rosenbaum, J.T., Strober, W., Kitani, A., NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology 133:5 (2007), 1510–1521, 10.1053/j.gastro.2007.07.025 [PMID: 17915219 PMCID: 2134971].
8. [8] Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., Wallace, J.L., Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:3 (1989), 795–803 [PMID: 2914642].
9. [9] Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E., Strober, W., Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:5 (1995), 1281–1290 [PMID: 7595199 PMCID: 2192205].
10. [10] Ikeda, M., Takeshima, F., Isomoto, H., Shikuwa, S., Mizuta, Y., Ozono, Y., Kohno, S., Simvastatin attenuates trinitrobenzene sulfonic acid-induced colitis, but not oxazalone-induced colitis. Dig. Dis. Sci. 53:7 (2008), 1869–1875, 10.1007/s10620-007-0102-0 [PMID: 18049901].
11. [11] Little, J.R., Eisen, H.N., Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry 5:11 (1966), 3385–3395 [PMID: 4165954].
12. [12] Elson, C.O., Sartor, R.B., Tennyson, G.S., Riddell, R.H., Experimental models of inflammatory bowel disease. Gastroenterology 109:4 (1995), 1344–1367 [PMID: 7557106].
13. [13] da Silva, M.S., Sanchez-Fidalgo, S., Talero, E., Cardeno, A., da Silva, M.A., Villegas, W., Souza Brito, A.R., de La Lastra, C.A., Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model. J. Ethnopharmacol. 128:2 (2010), 467–475, 10.1016/j.jep.2010.01.024 [PMID: 20083187].
14. [14] Takagi, T., Naito, Y., Mizushima, K., Akagiri, S., Suzuki, T., Hirata, I., Omatsu, T., Handa, O., Kokura, S., Ichikawa, H., Yoshikawa, T., Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-alpha expression. Dig. Dis. Sci. 55:10 (2010), 2797–2804, 10.1007/s10620-009-1112-x [PMID: 20094779].
15. [15] Mannon, P.J., Fuss, I.J., Mayer, L., Elson, C.O., Sandborn, W.J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R.L., Quezado, M., Yang, Z., Neurath, M.F., Salfeld, J., Veldman, G.M., Schwertschlag, U., Strober, W., Anti ILCsDSG. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351:20 (2004), 2069–2079, 10.1056/NEJMoa033402 [PMID: 15537905].
16. [16] Camoglio, L., te Velde, A.A., de Boer, A., ten Kate, F.J., Kopf, M., van Deventer, S.J., Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur. J. Immunol. 30:5 (2000), 1486–1495, 10.1002/(SICI)1521-4141(200005)30:5<1486::AID-IMMU1486>3.0.CO;2-8 [PMID: 10820397].
17. [17] Lees, C.W., Barrett, J.C., Parkes, M., Satsangi, J., New IBD genetics: common pathways with other diseases. Gut 60:12 (2011), 1739–1753, 10.1136/gut.2009.199679 [PMID: 21300624].
18. [18] Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease. Nature 474:7351 (2011), 307–317, 10.1038/nature10209 [PMID: 21677747 PMCID: 3204665].
19. [19] Becker, C., Dornhoff, H., Neufert, C., Fantini, M.C., Wirtz, S., Huebner, S., Nikolaev, A., Lehr, H.A., Murphy, A.J., Valenzuela, D.M., Yancopoulos, G.D., Galle, P.R., Karow, M., Neurath, M.F., Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 177:5 (2006), 2760–2764 [PMID: 16920909].
20. [20] Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov, I.I., Littman, D.R., Maloy, K.J., Powrie, F., Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:7293 (2010), 1371–1375, 10.1038/nature08949 [PMID: 20393462 PMCID: 3796764].
21. [21] de Almeida, A.B., Sanchez-Hidalgo, M., Martin, A.R., Luiz-Ferreira, A., Trigo, J.R., Vilegas, W., dos Santos, L.C., Souza-Brito, A.R., de la Lastra, C.A., Anti-inflammatory intestinal activity of Arctium lappa L. (Asteraceae) in TNBS colitis model. J. Ethnopharmacol. 146:1 (2013), 300–310, 10.1016/j.jep.2012.12.048 [PMID: 23313393].
22. [22] Isik, F., Tunali Akbay, T., Yarat, A., Genc, Z., Pisiriciler, R., Caliskan-Ak, E., Cetinel, S., Altintas, A., Sener, G., Protective effects of black cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats. Dig. Dis. Sci. 56:3 (2011), 721–730, 10.1007/s10620-010-1333-z [PMID: 20658190].
23. [23] Cheon, G.J., Cui, Y., Yeon, D.S., Kwon, S.C., Park, B.G., Mechanisms of motility change on trinitrobenzenesulfonic Acid-induced colonic inflammation in mice. Korean J. Physiol. Pharmacol. Off. J. Korean Physiol. Soc. Korean Soc. Pharmacol. 16:6 (2012), 437–446, 10.4196/kjpp.2012.16.6.437 [PMID: 23269907 PMCID: 3526749].
24. [24] Qin, H.Y., Wu, J.C., Tong, X.D., Sung, J.J., Xu, H.X., Bian, Z.X., Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome. J. Gastroenterol. 46:2 (2011), 164–174, 10.1007/s00535-010-0321-6 [PMID: 20848144].
25. [25] Randhawa, P.K., Singh, K., Singh, N., Jaggi, A.S., A review on chemical-induced inflammatory bowel disease models in rodents. Korean J. Physiol. Pharmacol. Off. J. Korean Physiol. Soc. Korean Soc. Pharmacol. 18:4 (2014), 279–288, 10.4196/kjpp.2014.18.4.279 [PMID: 25177159 PMCID: 4146629].
26. [26] Margonis, G.A., Christoloukas, N., Antoniou, E., Arkadopoulos, N., Theodoropoulos, G., Agrogiannis, G., Pikoulis, E., Patsouris, E.S., Zografos, G.C., Papalois, A.E., Effectiveness of sildenafil and U-74389G in a rat model of colitis. J. Surg. Res. 193:2 (2015), 667–674, 10.1016/j.jss.2014.08.064 [PMID: 25277360].
27. [27] Zhao, G., Li, J., Wang, J., Shen, X., Sun, J., Aquaporin 3 and 8 are down-regulated in TNBS-induced rat colitis. Biochem. Biophys. Res. Commun. 443:1 (2014), 161–166, 10.1016/j.bbrc.2013.11.067 [PMID: 24286754].
28. [28] Cury, D.B., Mizsputen, S.J., Versolato, C., Miiji, L.O., Pereira, E., Delboni, M.A., Schor, N., Moss, A.C., Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis. Cell. Immunol. 282:1 (2013), 66–70, 10.1016/j.cellimm.2013.04.004 [PMID: 23685388 PMCID: 4080304].
29. [29] Vermeulen, W., De Man, J.G., De Schepper, H.U., Bult, H., Moreels, T.G., Pelckmans, P.A., De Winter, B.Y., Role of TRPV1 and TRPA1 in visceral hypersensitivity to colorectal distension during experimental colitis in rats. Eur. J. Pharmacol. 698:1–3 (2013), 404–412, 10.1016/j.ejphar.2012.10.014 [PMID: 23099257].
30. [30] Abad, C., Martinez, C., Juarranz, M.G., Arranz, A., Leceta, J., Delgado, M., Gomariz, R.P., Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 124:4 (2003), 961–971, 10.1053/gast.2003.50141 [PMID: 12671893].
31. [31] Petrella, C., Giuli, C., Broccardo, M., Eutamene, H., Cartier, C., Leveque, M., Bedini, A., Spampinato, S., Bueno, L., Theodorou, V., Improta, G., Agostini, S., Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis. Pharmacol. Res. Off. J. Italian Pharmacol. Soc. 70:1 (2013), 72–79, 10.1016/j.phrs.2013.01.004 [PMID: 23353033].
32. [32] Chen, K., Long, Y.M., Wang, H., Lan, L., Lin, Z.H., Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis. World J. Gastroenterol. WJG 11:10 (2005), 1508–1514 [PMID: 15770728 PMCID: 4305694].
33. [33] Fitzpatrick, L.R., Meirelles, K., Small, J.S., Puleo, F.J., Koltun, W.A., Cooney, R.N., A new model of chronic hapten-induced colitis in young rats. J. Pediatr. Gastroenterol. Nutr. 50:3 (2010), 240–250, 10.1097/MPG.0b013e3181cb8f4a [PMID: 20118800].
34. [34] Rivera, E., Flores, I., Rivera, E., Appleyard, C.B., Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets. Inflamm. Bowel Dis. 12:10 (2006), 950–966, 10.1097/01.mib.0000231575.11678.8c [PMID: 17012966].
35. [35] Pohlmann, A., Tilling, L.C., Robinson, A., Woolmer, O., McCleary, S., Kruidenier, L., Warnock, L.C., Lewis, H.D., Hobson, A.R., James, M.F., Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI. Inflamm. Bowel Dis. 15:4 (2009), 534–545, 10.1002/ibd.20800 [PMID: 19058230].
36. [36] Charpentier, C., Marion-Letellier, R., Savoye, G., Nicol, L., Mulder, P., Aziz, M., Vera, P., Dechelotte, P., Savoye-Collet, C., Magnetic resonance colonography in rats with TNBS-induced colitis: a feasibility and validation study. Inflamm. Bowel Dis. 18:10 (2012), 1940–1949, 10.1002/ibd.22897 [PMID: 22262626].
37. [37] Natah, S.S., Mouihate, A., Pittman, Q.J., Sharkey, K.A., Disruption of the blood-brain barrier during TNBS colitis. Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc. 17:3 (2005), 433–446, 10.1111/j.1365-2982.2005.00654.x [PMID: 15916631].
38. [38] El-Salhy, M., Wendelbo, I.H., Gundersen, D., Hatlebakk, J.G., Hausken, T., Evaluation of the usefulness of colonoscopy with mucosal biopsies in the follow-up of TNBS-induced colitis in rats. Mol. Med. Rep. 8:2 (2013), 446–450, 10.3892/mmr.2013.1528 [PMID: 23778962].
39. [39] Lohman, R.J., Cotterell, A.J., Suen, J., Liu, L., Do, A.T., Vesey, D.A., Fairlie, D.P., Antagonism of protease-activated receptor 2 protects against experimental colitis. J. Pharmacol. Exp. Ther. 340:2 (2012), 256–265, 10.1124/jpet.111.187062 [PMID: 22028393].
40. [40] Yue, G., Lai, P.S., Yin, K., Sun, F.F., Nagele, R.G., Liu, X., Linask, K.K., Wang, C., Lin, K.T., Wong, P.Y., Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J. Pharmacol. Exp. Ther. 297:3 (2001), 915–925 [PMID: 11356911].
41. [41] Pilichos, C.J., Kouerinis, I.A., Zografos, G.C., Korkolis, D.P., Preza, A.A., Gazouli, M., Menenakos, E.I., Loutsidis, A.E., Zagouri, F., Gorgoulis, V.G., Fotiadis, C.I., The effect of nitric oxide synthases inhibitors on inflammatory bowel disease in a rat model. in vivo 18:4 (2004), 513–516 [PMID: 15369194].
42. [42] Brenna, O., Furnes, M.W., Drozdov, I., van Beelen Granlund, A., Flatberg, A., Sandvik, A.K., Zwiggelaar, R.T., Marvik, R., Nordrum, I.S., Kidd, M., Gustafsson, B.I., Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD. PloS one, 8(1), 2013, e54543, 10.1371/journal.pone.0054543 [PMID: 23382912 PMCID: 3561356].